BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 23755201)

  • 1. Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells.
    Osawa Y; Hoshi M; Yasuda I; Saibara T; Moriwaki H; Kozawa O
    PLoS One; 2013; 8(6):e65251. PubMed ID: 23755201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis.
    Uchinami H; Seki E; Brenner DA; D'Armiento J
    Hepatology; 2006 Aug; 44(2):420-9. PubMed ID: 16871591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice.
    Hara M; Kono H; Furuya S; Hirayama K; Tsuchiya M; Fujii H
    J Surg Res; 2013 Aug; 183(2):574-82. PubMed ID: 23578751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilostazol attenuates cholestatic liver injury and its complications in common bile duct ligated rats.
    Abdel Kawy HS
    Eur J Pharmacol; 2015 Apr; 752():8-17. PubMed ID: 25666386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrotic effects of a recombinant adeno-associated virus carrying small interfering RNA targeting TIMP-1 in rat liver fibrosis.
    Cong M; Liu T; Wang P; Fan X; Yang A; Bai Y; Peng Z; Wu P; Tong X; Chen J; Li H; Cong R; Tang S; Wang B; Jia J; You H
    Am J Pathol; 2013 May; 182(5):1607-16. PubMed ID: 23474083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmin plays a key role in the regulation of profibrogenic molecules in hepatic stellate cells.
    Martínez-Rizo A; Bueno-Topete M; González-Cuevas J; Armendáriz-Borunda J
    Liver Int; 2010 Feb; 30(2):298-310. PubMed ID: 19889106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
    Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
    J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human antigen R contributes to hepatic stellate cell activation and liver fibrosis.
    Woodhoo A; Iruarrizaga-Lejarreta M; Beraza N; García-Rodríguez JL; Embade N; Fernández-Ramos D; Martínez-López N; Gutiérrez-De Juan V; Arteta B; Caballeria J; Lu SC; Mato JM; Varela-Rey M; Martínez-Chantar ML
    Hepatology; 2012 Nov; 56(5):1870-82. PubMed ID: 22576182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice.
    Copple BL; Kaska S; Wentling C
    J Pharmacol Exp Ther; 2012 May; 341(2):307-16. PubMed ID: 22271822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 participates in the progression from liver injury to fibrosis.
    Gieling RG; Wallace K; Han YP
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1324-31. PubMed ID: 19342509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.
    Mormone E; Lu Y; Ge X; Fiel MI; Nieto N
    Gastroenterology; 2012 Mar; 142(3):612-621.e5. PubMed ID: 22138190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naringin from Ganshuang granule inhibits inflammatory to relieve liver fibrosis through TGF-β-Smad signaling pathway.
    Wang F; Gan J; Li R; Yang R; Mao X; Liu S; Chen Y; Duan Z; Li J
    PLoS One; 2024; 19(6):e0304185. PubMed ID: 38857261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis.
    Xie L; Chen H; Zhang L; Ma Y; Zhou Y; Yang YY; Liu C; Wang YL; Yan YJ; Ding J; Teng X; Yang Q; Liu XP; Wu J
    Clin Mol Hepatol; 2024 Apr; 30(2):206-224. PubMed ID: 38190829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
    Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
    BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective activation of Toll-like receptor 7 in activated hepatic stellate cells may modulate their profibrogenic phenotype.
    Chou MH; Huang YH; Lin TM; Du YY; Tsai PC; Hsieh CS; Chuang JH
    Biochem J; 2012 Oct; 447(1):25-34. PubMed ID: 22765640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
    Sugino H; Kumagai N; Watanabe S; Toda K; Takeuchi O; Tsunematsu S; Morinaga S; Tsuchimoto K
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. iRhom2 inhibits bile duct obstruction-induced liver fibrosis.
    Sundaram B; Behnke K; Belancic A; Al-Salihi MA; Thabet Y; Polz R; Pellegrino R; Zhuang Y; Shinde PV; Xu HC; Vasilevska J; Longerich T; Herebian D; Mayatepek E; Bock HH; May P; Kordes C; Aghaeepour N; Mak TW; Keitel V; Häussinger D; Scheller J; Pandyra AA; Lang KS; Lang PA
    Sci Signal; 2019 Oct; 12(605):. PubMed ID: 31662486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17 and TNF-α co-operation contributes to the proinflammatory response of hepatic stellate cells.
    Beringer A; Miossec P
    Clin Exp Immunol; 2019 Oct; 198(1):111-120. PubMed ID: 31102558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.